Location History:
- Jiansgu, CN (2018)
- Jiangsu, CN (2019 - 2022)
Company Filing History:
Years Active: 2018-2022
Title: Qingli Bao: Innovator in Pharmaceutical Chemistry
Introduction
Qingli Bao is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 3 patents to his name, Bao is recognized for his innovative approach to drug discovery.
Latest Patents
One of Qingli Bao's latest patents is focused on 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors. This patent discloses the use of these compounds, represented by the Formula (I), for their potential therapeutic effects. The development of PARP inhibitors is crucial in the treatment of various cancers, showcasing Bao's commitment to advancing medical science.
Career Highlights
Qingli Bao is currently associated with Impact Therapeutics, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in medicinal chemistry has positioned him as a valuable asset in the research and development of new therapeutic agents.
Collaborations
Throughout his career, Bao has collaborated with notable colleagues, including Sui Xiong Cai and Ye Edward Tian. These partnerships have fostered a collaborative environment that enhances the research output and innovation within the team.
Conclusion
Qingli Bao's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a leading inventor in the field. His work continues to impact the development of new therapies, demonstrating the importance of innovation in healthcare.